Skip to site menu Skip to page content

A Game Changer for High-Risk Medications via Intranasal Drug Delivery Platform

By Ursatec
In this article, Marcel Botha, chief executive officer at Validose, Andreas Bilstein, PhD, general manager, and Houssam Elghobary, business development and sales manager, both at Ursatec, and Rouven Kraus, head of sales at Aero Pump, discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content